Sinsin Pharmaceutical Co., Ltd. - search results

United States - English - NLM (National Library of Medicine)

ginsenggo- camphor, menthol, methyl salicylate patch

sinsin pharmaceutical co., ltd. - dl-camphor 0.70%, l-menthol 1.40%, methyl salicylate 2.80% - topical analgesic for temporary relief of minor pain associated with: - arthritis - simple backache - tendonitis - muscle strains - muscle sprains - bruises - on wounds or damaged skin - with, or at the same time as, other external analgesic products. - use only as directed - do not bandage tightly or use with heating pad. - avoid contact with the eyes and mucous membranes. - conditions worsens. - symptoms persist more than 7 days or clear up and occur again within a few days. - rash, itiching, or excessive irritation develops. if swallowed, get medical help or contact a poison control center right away.

United States - English - NLM (National Library of Medicine)

scarderm- allantoin gel

sinsin pharmaceutical co., ltd. - allantoin (unii: 344s277g0z) (allantoin - unii:344s277g0z) - skin protectant temporatrily protects and helps relieve chapped or cracked skin

United States - English - NLM (National Library of Medicine)

levetiracetam- levetiracetam tablet, film coated

lotus pharmaceutical co., ltd. nantou plant - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 750 mg - levetiracetam tablets, usp are indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam tablets, usp are indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam tablets, usp are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. none. levetiracetam blood levels may decrease during pregnancy [ see warnings and precautions (5.9) ]. pregnancy category c there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam should be used during pregnancy only if the potential benefit justifies the potent

United States - English - NLM (National Library of Medicine)

levetiracetam extended-release - levetiracetam tablet

lotus pharmaceutical co., ltd. nantou plant - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 750 mg - levetiracetam extended-release tablets is indicated as adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. none. levetiracetam extended-release tablets levels may decrease during pregnancy [see warnings and precautions (5.8) ]. pregnancy category c there are no adequate and well-controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam extended-release tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of levetiracetam to female rats throughout pregnancy and lactation led to increased incidences of minor fetal skeletal abnormalities and retarded offspring growth pre- and/or postnatally at doses ≥350 mg/kg/day (equivalent to the maximum recommended human dose of 3,000 mg [mrhd] on a mg/m2 basis) and with

United States - English - NLM (National Library of Medicine)

temozolomide capsule

lotus pharmaceutical co., ltd.nantou plant - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide 5 mg